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Abstract  Fanconi  anemia  is  a  rare  autosomal  recessive  inherited  bone  marrow  failure  syn-
drome  with  congenital  and  hematological  abnormalities.  Literature  regarding  the  anesthetic
management  in  these  patients  is  limited.  A  management  of  a  developmental  dislocation  of  the
hip  was  described  in  a  patient  with  fanconi  anemia.  Because  of  the  heterogeneous  nature,  a
patient  with  fanconi  anemia  should  be  established  thorough  preoperative  evaluation  in  order  to
diagnose  on  clinical  features.  In  conclusion,  we  preferred  caudal  anesthesia  in  this  patient  with
fanconi  anemia  without  thrombocytopenia,  because  of  avoiding  from  N2O,  reducing  amount
of  anesthetic,  existing  microcephaly,  hypothyroidism  and  elevated  liver  enzymes,  providing
postoperative  analgesia,  and  reducing  amount  of  analgesic  used  postoperatively.
© 2013  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  
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Fanconi  anemia  (FA)  is  a  rare  autosomal  recessive  inherited
bone marrow  failure  syndrome,  characterized  by  increased
chromosomal fragility,  and  generally  associated  with  multi-
ple congenital  anomalies.1
Literature  regarding  the  anesthetic  management  in  these
patients is  limited.  A  management  of  a  developmental  dis-
location of  the  hip  was  described  in  a  patient  with  FA.
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 2.5-year-old  girl,  born  to  ﬁrst  degree  consanguineous  par-
nts presented  with  a  failure  to  walking.  She  was  delivered
y spontaneous  vaginal  in  time  and  small  for  gestational
ge, weighing  2.2  kg  at  birth.  Physical  examination  revealed
etarded growth  (5.7  kg  weight  and  68  cm  height)  with
bsence of  bilateral  thumb  (Fig.  1),  café  au  lait  spots  at
ack, hypopigmentation  at  abdomen,  generalized  hyperpig-
entation, and  microcephaly.
Laboratory investigations  did  not  reveal  pancytope-
ia; hemoglobin,  WBC  and  platelets  were  11.4  g  dl−1,
.4 ×  103 dl−1 and  162  ×  103 dl−1 respectively.  ALP,  GGT  and
lsevier Editora Ltda. Este é um artigo Open Access sob a licença de CC BY-NC-ND
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bFigure  1  Absence  of  the  thumb.
DH  levels  were  elevated  and  564,  420  and  289  respectively.
ltrasound revealed  hypoplastic  horseshoe  kidney.
The  patient’s  medication  included  only  levothyroxine
ecause of  hypothyroidism.  No  medication  exist  related  FA.
Other  investigations  including  electrolytes,  BUN,  cre-
tinine, bilirubins,  AST,  ALT,  prothrombin  time,  partial
hromboplastin time,  ECG,  and  echocardiogram  were  nor-
al. The  patient  was  euthyroidic.
Evaluation  of  the  airway  revealed  no  abnormalities,
xcept microcephaly,  and  vital  signs  were  normal.  Adequate
lood and  blood  products  ordered  depending  on  the  proce-
ure.
No medication  was  administered  prior  to  the  procedure
part from  antibiotics.  Anesthesia  was  induced  with  8%
evoﬂurane in  100%  oxygen.  After  peripheral  i.v.  access  was
ecured, she  was  turned  to  the  left  lateral  position.  Cau-
al block  was  performed  by  using  a  22-gauge  short-bevel
eedle under  aseptic  conditions  with  bupivacaine  0.25%  at
 ml  kg−1.  After  caudal  blockade  inhalation  anesthesia  was
owered to  0.5--1%  in  100%  oxygen  in  order  to  obtain  4  or
 point  of  Ramsay  sedation  scale.  Peripheral  oxygen  satu-
ation (SpO2),  heart  rate,  noninvasive  blood  pressure  and
nd-tidal CO2 (ETCO2)  were  monitored  throughout  surgery.
entilation was  maintained  via  an  oxygen  mask  with  2  L  dk−1
resh  ﬂow  spontaneously  (Fig.  2).
Whole  procedure  including  open  reduction  and  putting
he limb  in  a  plaster  cast  from  induction  to  recovery  lasted
40 min  and  was  uneventful.  Recovery  was  fast  and  unevent-
ul. Postoperative  analgesia  was  not  required  for  ten  hours.
Figure  2  The  patient  with  facemask  during  surgery.
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iscussion
anconi  anemia  is  an  autosomal  recessive  disorder  in  over
9% of  cases  with  25%  risk  to  siblings.1 The  incidence  of  FA  is
pproximately three  per  million  and  the  heterozygote  fre-
uency is  estimated  at  one  in  300  in  Europe  and  the  USA,2
/100  in  Ashkenazi  Jews  and  South  African  Afrikaners  due
o ‘‘founder  effect’’.1,3 Consanguinity  has  been  implicated
n its  incidence.3
Clinical  features  of  FA  can  be  broadly  divided  into
wo categories:  congenital  abnormalities  and  hematological
bnormalities, which  may  include  altered  skin  pigmenta-
ion and/or  café  au  lait  spots,  short  stature  (impaired
rowth hormone  secretion),  thumb  or  thumb  and  radial
nomalies, hip  anomalies,  vertebral  scoliois,  rib  anoma-
ies, male  hypogenitalism,  mental  retardation,  anorectal
tresia, duodenal  atresia,  microcephaly,  eye  anomalies
microphthalmia, strabismus,  ptosis,  nystagmus),  struc-
ural renal  defects,  low-birth  weight,  developmental  delay,
bnormal ears  or  hearing,  and  cardiopulmonary  defects.1--3
he  most  important  clinical  features  of  FA  are  hemato-
ogical. Pancytopenia  is  the  usual  ﬁnding  and  typically
resents between  the  ages  of  5  and  10  years,  the  median
ge of  onset  being  7  years.1 Clinically,  the  affected  FA
atient may  present  with  bleeding,  pallor  and/or  recur-
ing infections.2 The  major  cause  of  death  in  FA  is  bone
arrow failure,  followed  in  frequency  by  leukemia  and
olid tumors.  The  projected  median  survival  from  all  causes
or more  than  1000  cases  reported  in  the  literature  is
ge 20  years.3 Of  patients  thirty  or  forty  percent  lack
bvious physical  abnormalities.1--3 There  is  great  clinical
eterogeneity even  within  a  genotype  (sibling  may  be  phe-
otypically different).1 The  gold-standard  screening  test
or FA  is  based  on  the  characteristic  hypersensitivity  of
A cells  to  the  crosslinking  agents,  such  as  mitomycin  C
MMC) or  diepoxybutane  (DEB).5 FANCA  is  the  most  com-
on complementation  group,  representing  about  70%  of
ases.1 Androgen  therapy  (oxymetholone),  cytokines  (G-
SF and  GM-CSF),  and  supportive  therapies  such  as  blood
nd platelet  transfusions  form  the  mainstay  of  treatment
rior to  allogeneic  hematopoietic  stem  cell  transplantation.
ene therapy  is  experimental.  E-amino  caproic  acid  may
e used  for  symptomatic  bleeding.  Steroids  are  occasion-
lly used.1--3 FA  frequently  terminates  in  myelodysplastic
yndrome and/or  leukemia.1 Hematopoietic  stem  cell  trans-
lantation (bone  marrow,  cord  blood,  or  peripheral  blood
tem cells)  may  cure  aplastic  anemia  and  prevent  myelodys-
lastic syndrome  or  leukemia.2,3
Patients  with  FA  may  present  for  procedures  such  as  Hick-
an catheter  insertion  for  bone  marrow  transplantation,
imb reconstructive  surgeries,  splenectomy,  gastrointesti-
al anomalies,  congenital  heart  defects,  trauma  or  other
elated and/or  non-related  indications.  The  insufﬁciency  of
iterature regarding  anesthetic  management  of  this  condi-
ion makes  it  difﬁcult  to  estimate  the  real  impact  of
ndividual anomalies  on  the  perioperative  management.6 It
s important  to  emphasize  that  of  patients  thirty  or  forty
ercent have  no  abnormalities.1--3Because  of  the  heterogeneous  nature  of  the  condi-
ion, FA  is  difﬁcult  to  diagnose  on  clinical  features.2 A
horough preoperative  evaluation  includes  airway  exami-
ation, and  hematological,  cardiopulmonary,  hepatorenal
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and  endocrine  evaluation  for  any  component  of  the  dis-
ease or  any  complication  of  the  treatment  of  the  disease.
For example  hyperbilirubinemia  and  hepatomegaly  with
fatty inﬁltrates  could  be  attributed  to  therapy  with  andro-
gen. All  transfusions  and  any  transfusion  reactions  must  be
documented.6 Adequate  blood  and  blood  products  should
be ordered  depending  on  the  procedure.  No  family  mem-
ber should  be  used  as  a  blood  product  donor  until  it  has
been determined  that  a  transplant  will  not  be  performed.3
Leukocyte-ﬁltered  blood  products  should  be  used  to  reduce
reactions and  HLA  sensitization  in  case  of  future  stem  cell
transplant. Similarly,  single-donor  platelets  are  preferred  to
reduce the  frequency  of  antibody  formation.3
Because  thrombocytopenia  usually  develops  initially,4
particularly,  thrombocyte  count  should  be  evaluated.
Repeated respiratory  tract  infections  and  neutropenic  sep-
sis  may  be  present  because  of  pancytopenia.  Children  with
neutropenic sepsis  may  have  subclinical  coagulopathy  that
should be  corrected  preoperatively.7 In  case  of  neutropenia,
it is  mandatory  to  maintain  strict  aseptic  precautions  while
handling these  patients.  Bacterial  and  viral  ﬁlters  should  be
used in  the  breathing  circuits.6
Endocrinopathies  are  a  common  feature  of  FA.  In
a prospective  study  of  54  FA  patients,  it  was  found
that hypothyroidism,  impaired  glucose  tolerance,  hyper-
insulinemia, and  subnormal  response  to  growth  hormone
stimulation.7 A  complete  endocrine  assessment  should  be
made to  detect  these  aspects.  Patients,  who  are  on  steroid
therapy, must  be  documented  regarding  replacement  ther-
apy, glucose  monitoring,  edema,  hypokalemia,  myopathy,
infection, and  gastric  prophylaxia.
Drug  therapy  for  FA  may  also  have  anesthetic  impli-
cations. Some  of  the  serious  adverse  effects  of  androgen
include hepatomegaly,  cholestatic  hepatitis,  and  elevated
liver enzyme  levels.3 Androgens  may  increase  the  anticoag-
ulant effect  of  oral  anticoagulants  (warfarin)8 and  may  also
increase insulin  effects.9 Adverse  effects  of  G-CSF  treatment
relevant to  anesthetic  management  include  pericardial  and
pleural effusions  and  generalized  capillary  leak  syndromes,
which may  result  in  interstitial  pulmonary  edema  and  arte-
rial hypoxemia.10
Other  drugs  and  chemicals  causing  acquired  aplastic  ane-
mia should  be  avoided  during  the  perioperative  period.
Medications interfere  with  platelet  function  should  not  be
given to  thrombocytopenic  patients.3 These  include  aspirin,
antihistamines, and  nonsteroidal  anti-inﬂammatory  drugs.6
Normal  fasting  regimes  and  minimal  monitoring  stan-
dards, if  any  indication  exist,  more  monitorizations,  should
be applied  throughout  the  perioperative  period.  Signiﬁ-
cant thrombocytopenia,  if  present,  may  preclude  regional
anesthesia. Infective  endocarditis  prophylaxis  has  to  be  con-
sidered for  patients  with  cardiac  involvement.6
A  possible  anesthetic  consideration  may  include  the
avoidance of  high  inspired  oxygen  concentrations  (FiO2).
There is  sensitivity  to  oxygen-free  radicals  and  to  ionizing
radiation.1 Clarke  et  al.  suggest  that  the  sensitivity  of  FA
group C  cells  to  apoptosis  induced  by  MMC  is  because  of
reactive oxygen  species  generation  in  the  presence  of  high
oxygen concentrations  and  not  DNA  cross-linking.11 Low  oxy-
gen tension  or  antioxidants  may  be  used  to  improve  growth
and decrease  spontaneous  or  induced  chromosome  breaks  in
FA cells.3203
In  this  case  caudal  anesthesia  was  preferred  to  avoid  from
2O,  to  reduce  amount  of  anesthetic  agent,  to  provide  post-
perative analgesia,  and  to  reduce  amount  of  nonsteroidal
nti-inﬂammatory drugs  and  morphine.
Caudal  epidural  blockade  is  widely  used  to  provide
erioperative analgesia  in  pediatric  practice.  As  a  single
njection, it  offers  a  reliable  and  effective  block  for  patients
ndergoing subumbilical  surgery.12
Nitrous  oxide-induced  bone  marrow  depression  is  an  addi-
ional concern.  Some  studies  suggest  that  the  use  of  nitrous
xide (N2O)  is  harmful  producing  bone  marrow  suppres-
ion as  it  impairs  methionine  synthetase  activity,  disturbing
olate metabolism  and  thus  vitamin  B12  metabolism.13 On
he other  hand,  we  do  not  have  any  data  in  patient  with  FA.
In  view  of  the  hepatorenal  derangement  which  can
ccur any  time  during  the  course  of  the  disease,  it  is
mperative to  avoid  anesthetic  agents  with  potential  hep-
torenal toxicity.  In  this  respect,  it  may  be  advisable  to
void halothane,  long-acting  muscle  relaxants,  nonsteroidal
nti-inﬂammatory agents,  and  long-acting  opioids  such  as
orphine and  pethidine.6 Postoperative  analgesia  could
e provided  by  caudal  injection  perfectly.  Thus,  amount
f analgesic  drug,  such  as  nonsteroidal  anti-inﬂammatory
gents, morphine  and  pethidine,  could  be  reduced.  In  this
anner potential  hepatorenal  toxicity  owing  to  analgesic
gent could  be  avoided.
In conclusion,  we  preferred  in  the  patient  with  FA  without
hrombocytopenia, because  of  avoiding  from  N2O,  reducing
mount of  anesthetic,  existing  microcephaly,  hypothy-
oidism and  elevated  liver  enzymes,  providing  postoperative
nalgesia, and  reducing  amount  of  analgesic  used  postopera-
ively.
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